Press Releases
Virpax Pharmaceuticals Partners with MedPharm for Successful Completion of Pre-IND Meeting with FDA on Epoladerm
Virpax Pharmaceuticals Inc., a company specializing in developing pharmaceutical products for pain management by using new drug delivery systems, has announced that it had...
Clinical Trials
US pharma firm Gilead Sciences likely to seek nod to market anti-viral drug remdesivir in India
US pharmaceutical giant Gilead Sciences is likely to apply to India's Central Drugs Standard Control Organisation (CDSCO) soon seeking marketing authorisation for its anti-viral...
Press Releases
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a number of countries and multilateral organisations to make...
Clinical Trials
Pfizer reports gene therapy data from Phase Ib DMD trial
Pfizer has reported new data from the Phase Ib clinical trial of PF-06939926 for the treatment of patients with Duchenne muscular dystrophy (DMD).
PF-06939926 is...
Clinical Trials
Abivax gets approval to conduct Covid-19 trial in France
Biotechnology company Abivax has secured approval from France’s National Agency for the Safety of Medicines (ANSM) and French Ethics Committee (CPP) to conduct a...
IT & Data Management
Indica Labs and Octo launch COVID digital pathology repository to support the fight against COVID-19
Indica Labs, a leading provider of computational pathology software, and Octo, a premiere information technology systems provider to the U.S. Federal Government, are pleased...
Press Releases
Roche’s Tecentriq receives US FDA approval for first-line monotherapy for certain people with metastatic NSCLC
Roche announced that the US FDA has approved Tecentriq® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read